
Fri 9 January 2026
Warszawa (PL)
Fri 9 January 2026
Praha (CZ)
Fri 9 January 2026
Bratislava (SK)
Fri 9 January 2026
Budapest (HU)



September 23rd, 2020
A Polish biotech company, Biomed Lublin, said on Wednesday it has successfully completed the production of the first batch of the world's first medicine to be used in COVID-19 treatment. So far more than 3,000 vials of the anti-SARS-CoV-2 immunoglobulin have been produced, Biomed Lublin CEO Marcin Pirog said, as cited in the Wednesday press release.
PAP
Pageviews this month:
63,741